Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Case Report

Volume 7, Number 3, June 2017, pages 94-97


Effect of Tofogliflozin on Cardiac Function: Potential Link Between Ketone Bodies and the Heart

Table

Table 1. Changes of Cardiometabolic Parameters
 
Patient APatient BPatient C
These parameters are measured at baseline and at 3 months.
Age (years)656860
Body height (cm)162168165
CTR (%)585055
Body weight (kg)
  Baseline64.28976.85
  3 months63.0590.277.45
HbA1c (%)
  Baseline7.38.99.8
  3 months7.611.49
EF
  Baseline47.869.347.7
  3 months61.166.547.7
%FS
  Baseline24.838.924.4
  3 months33.136.724.4
BNP (pg/mL)
  Baseline71.77.255.7
  3 months17.14.753.7
Acetoacetate (µmol/L)
  Baseline196330
  3 months293630
Beta-hydroxybutyrate (µmol/L)
  Baseline4614275
  3 months538388
Hb (g/dL)
  Baseline12.916.514.6
  3 months11.315.514.5